Brief: Epigenomics Completes Capital Increase
18/05/2021 07:53
May 18 (Reuters) - EPIGENOMICS AG ECXn.DE :
* SUCCESSFULLY COMPLETES CAPITAL INCREASE
* GROSS PROCEEDS FROM CAPITAL INCREASE AMOUNT TO
APPROXIMATELY EUR
2.2 MILLION
Source text for Eikon: ID:nEQrPkbCa
Further company coverage: ECXn.DE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns